OVERSEA CHINESE BANKING Corp Ltd Sells 156 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

OVERSEA CHINESE BANKING Corp Ltd trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 14.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 904 shares of the biotechnology company’s stock after selling 156 shares during the period. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Axon Enterprise were worth $234,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Sands Capital Management LLC raised its stake in Axon Enterprise by 31.1% during the third quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after buying an additional 619,179 shares during the last quarter. Wellington Management Group LLP boosted its stake in Axon Enterprise by 3.3% in the 3rd quarter. Wellington Management Group LLP now owns 1,956,022 shares of the biotechnology company’s stock worth $389,229,000 after purchasing an additional 62,324 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Axon Enterprise by 28.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 726,400 shares of the biotechnology company’s stock worth $144,546,000 after purchasing an additional 160,359 shares in the last quarter. Westfield Capital Management Co. LP grew its position in Axon Enterprise by 184.3% during the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after purchasing an additional 451,350 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in Axon Enterprise by 3.1% in the third quarter. Northern Trust Corp now owns 631,212 shares of the biotechnology company’s stock worth $125,605,000 after buying an additional 19,068 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

AXON has been the subject of several analyst reports. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. JMP Securities lifted their target price on Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 6th. TheStreet downgraded Axon Enterprise from a “b” rating to a “c+” rating in a report on Tuesday, February 27th. Argus began coverage on Axon Enterprise in a report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price objective for the company. Finally, StockNews.com cut shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $312.64.

Axon Enterprise Trading Up 0.1 %

Shares of Axon Enterprise stock opened at $293.80 on Tuesday. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87. The company’s fifty day simple moving average is $301.41 and its 200-day simple moving average is $259.57. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The stock has a market capitalization of $22.17 billion, a PE ratio of 127.74 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.29. The company had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. As a group, equities analysts anticipate that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.